Stock Movers

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostic, Carol Massar and Tim Stenovec
- Bloom Energy (BE) and Everpure shares are rising on Tuesday after S&P Dow Jones Indices said the companies will join the S&P 500 Index, effective prior to the open of trading on Sept. 21.

- Amgen (AMGN) declines after BMO Capital Markets cut its recommendation on the pharmaceutical company to market perform from outperform, while shares in biotechnology companies slumped after Novartis suffered its third clinical-trial setback in a week.

- Constellation Brands (STZ) shares are down as much as 3.7%, to the lowest intraday since April 2020, as CEO Nick Fink and EVP/CFO Garth Hankinson speak at the Barclays consumer conference
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market, a look at the notable movers:
On this episode of Stock Movers:

- Qualcomm (QCOM) signed an agreement with Amazon.com Inc. to create customized chips for Amazon Web Services' AI infrastructure. The agreement gives Amazon the right to acquire as much as $4 billion in Qualcomm stock and will last through "multiple generations" of equipment. Qualcomm will start to book revenue from Amazon in its fiscal first quarter and has expressed confidence that it will achieve a $5 billion data center revenue target for fiscal 2027. Qualcomm investors applauded the agreement, sending the shares up as much as 8.7% to $183.49 in New York. It was their biggest intraday gain since June 25.

- Boston Scientific (BSX) and Stryker (SYK) shares fell after the companies said they are dealing with the repercussions of separate cyber attacks. The cyber attacks curtailed the companies' ability to get products to customers and dented sales, with damage that could last for months. Both companies sell medical devices and are working to recover from the cyber incidents, with Boston Scientific's full operational recovery timeline remaining uncertain. Boston Scientific fell as much as 4.9% Tuesday in New York, while Stryker was down as much as 9.1%.

- Constellation Brands (STZ) shares are down as much as 3.7%, to the lowest intraday since April 2020, as CEO Nick Fink and EVP/CFO Garth Hankinson speak at the Barclays consumer conference.
See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
Amgen (AMGN) shares tumble. Shares of makers of heart drugs like Ionis Pharmaceuticals and Amgen are lower after Novartis AG said its heart medication, pelacarsen, failed in a final-stage study.
Oracle (ORCL) shares gain. Analysts are growing optimistic about the software company’s upcoming results, due after the market close on Thursday. The stock is on track for a fourth straight positive session, and has gained 19% over that stretch.
Bloom Energy (BE) shares gain. Bloom Energy and Everpure shares are rising on Tuesday after S&P Dow Jones Indices said the companies will join the S&P 500 Index, effective prior to the open of trading on Sept. 21.
See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- SpaceX (SPCX) shares rise. SpaceX's weighting in the Nasdaq 100 Index is expected to rise after the index's next rebalancing, which is set to be announced on Friday and take effect on Sept. 21. The increase in weighting could force $12.4 billion of net passive buying from index funds and ETFs, according to revised estimates by JPMorgan Securities strategists.
- Qualcomm (QCOM) shares gain. Qualcomm Inc. said it signed up Amazon.com Inc. as a data center chip customer in a deal that will span "multiple generations" and gives Amazon the right to acquire as much as $4 billion in shares. The tie-up will create customized silicon to support Amazon Web Services artificial intelligence infrastructure, with the two working on chips that run AI services and others that connect computer components.
- Roivant (ROIV) shares climb. The drugmaker said a mid-stage study of its inhaled drug, mosliciguat, met its primary endpoint in the treatment for a lung disease.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Novartis (NOVN) shares are lower as it suffered its third clinical-trial setback in a week after a treatment for a rare muscle-wasting disease failed a late-stage study.
- Boston Scientific (BSX) shares are moving on news it said that fallout from a cybersecurity incident has impacted its ability to ship its products to customers and will cause the medical devices company to miss its sales growth and earnings estimates for the year.
- Intel (INTC) is rising on a report that the company could raise computer chip prices next month.
See omnystudio.com/listener for privacy information.